Gagnon Securities’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
Other funds holding ATNM
AIS
Gagnon Securities's ATNM Position: Q3 2026 in Review
Gagnon Securities held its Actinium Pharmaceuticals (ATNM) position steady in Q3 2026 at 182,142 shares worth $204K. The position accounts for 0.04% of the portfolio, ranked #82.
Gagnon Securities first reported a position in ATNM in Q1 2025 and has held it in 7 quarters since. The position peaked at $365K in Q1 2025. 46 funds tracked by Wall St. Rank hold ATNM as of Q3 2026.
- Gagnon Securities held 182,142 shares of Actinium Pharmaceuticals worth $204K as of Q3 2026.
- Gagnon Securities left its Actinium Pharmaceuticals share count unchanged in Q3 2026.
- Actinium Pharmaceuticals made up 0.04% of Gagnon Securities's portfolio in Q3 2026, its #82 holding.
- Gagnon Securities first reported a position in Actinium Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- Gagnon Securities's Actinium Pharmaceuticals position peaked at $365K in Q1 2025.
- 46 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2026.
Based on Gagnon Securities's 13F filing for Q3 2026, filed 5 Nov 2026.